Refreshing . . .As governments scramble to reform the prescription drug market in Canada, Towers Watson today announced the launch of the Canadian Rx Coalition, a ground-breaking new way for employers to manage employee drug plans through a cooperative alliance with other Canadian plan sponsors.
Companies that completed deals during the first quarter of 2010 outperformed the market, according to Towers Watson’s Quarterly Deal Performance Monitor. The results show that M&A deals are continuing to create rather than destroy value.
A vast majority of Canadian employers are taking steps to address the ongoing funding crisis facing their defined benefit (DB) pension plans, according to a new survey from Towers Watson, a global professional services company. The majority of employers surveyed also believe the pension funding crisis is likely to remain beyond the next few years.
The ‘Great Recession’ may have ended, but its impact on the views of the Canadian workforce may, quite literally, be life-long, according to the results of new research from global professional services company Towers Watson. The Global Workforce Study – a biennial survey of employee attitudes and workplace trends – confirms that the recession has altered the way employees view their work today.
Towers Watson & Co. announced today the completion of the merger of Towers Perrin and Watson Wyatt. The transaction to form Towers Watson, a leading global professional services company, was announced on June 28, 2009. Watson Wyatt Chief Executive Officer John Haley will serve as Towers Watson’s Chairman and Chief Executive Officer; Towers Perrin Chief Executive Officer Mark Mactas will serve as Deputy Chairman, President and Chief Operating Officer.
Towers, Perrin, Forster & Crosby, Inc. and Watson Wyatt Worldwide, Inc. (NYSE, NASDAQ: WW), both leading global consulting firms, announced that at their respective special meetings of shareholders, each held earlier today, their shareholders adopted the merger agreement pursuant to which the companies will combine their businesses.
Towers, Perrin, Forster & Crosby, Inc. and Watson Wyatt Worldwide, Inc. (NYSE, NASDAQ: WW), both leading global consulting firms, today announced that they have been granted conditional clearance from the European Commission to allow the Parties to proceed with their merger to form Towers Watson & Co. U.S. antitrust authorities previously cleared the transaction.
Towers, Perrin, Forster & Crosby, Inc. and Watson Wyatt Worldwide, Inc. (NYSE, NASDAQ: WW) today announced that Jupiter Saturn Holding Company (“Jupiter Saturn”), the new entity formed as part of the merger process between Towers Perrin and Watson Wyatt, filed a registration statement on Form S-4 with the Securities and Exchange Commission.
Towers, Perrin, Forster & Crosby, Inc. and Watson Wyatt Worldwide, Inc. (NYSE, NASDAQ: WW) today announced that their respective Boards of Directors have unanimously approved a definitive agreement under which Towers Perrin and Watson Wyatt will combine in a merger of equals to form a new, publicly listed company called Towers Watson & Co.
David Le Roy
+1 416 960 7558
david.leroy@towerswatson.com
Whitney Kuhn
+1 703 258 7648
whitney.kuhn@towerswatson.com
Towers Watson is a leading global professional services company that helps organizations improve performance through effective people, risk and financial management. With 14,000 associates around the world, we offer solutions in the areas of employee benefits, talent management, rewards, and risk and capital management.
Towers Watson
Global Headquarters: